Neurocrine Biosciences Inc financial data

Symbol
NBIX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
6027 Edgewood Bend Court, San Diego, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 10, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 345 % +28.5%
Quick Ratio 8.93 % +55.6%
Debt-to-equity 37.5 % -11.7%
Return On Equity 13.4 % +4.12%
Return On Assets 9.73 % +7.87%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 99.7M shares +0.2%
Common Stock, Shares, Outstanding 99.4M shares +0.71%
Entity Public Float 10.5B USD +32.9%
Common Stock, Value, Issued 100K USD 0%
Weighted Average Number of Shares Outstanding, Basic 100M shares +2.76%
Weighted Average Number of Shares Outstanding, Diluted 104M shares +2.67%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 2.36B USD +24.8%
Costs and Expenses 1.78B USD +9.08%
Operating Income (Loss) 571M USD +127%
Nonoperating Income (Expense) -84.5M USD -204%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 486M USD +46.3%
Income Tax Expense (Benefit) 145M USD +75.6%
Net Income (Loss) Attributable to Parent 341M USD +36.7%
Earnings Per Share, Basic 3.4 USD/shares +32.8%
Earnings Per Share, Diluted 3.29 USD/shares +33.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 233M USD -7.21%
Accounts Receivable, after Allowance for Credit Loss, Current 479M USD +9.06%
Inventory, Net 57.4M USD +49.9%
Other Assets, Current 112M USD +14.6%
Assets, Current 1.72B USD +7.32%
Deferred Income Tax Assets, Net 486M USD +33.9%
Property, Plant and Equipment, Net 82.6M USD +16.7%
Operating Lease, Right-of-Use Asset 509M USD +84.2%
Intangible Assets, Net (Excluding Goodwill) 36.5M USD +2.82%
Goodwill 5.7M USD -1.72%
Other Assets, Noncurrent 15.5M USD -68.8%
Assets 3.72B USD +14.4%
Employee-related Liabilities, Current 108M USD +24.7%
Liabilities, Current 508M USD -22.5%
Accrued Income Taxes, Noncurrent 161M USD +67.4%
Operating Lease, Liability, Noncurrent 455M USD +76.2%
Other Liabilities, Noncurrent 121M USD +192%
Liabilities 1.13B USD +10.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax 5.8M USD -17.1%
Retained Earnings (Accumulated Deficit) 29.2M USD
Stockholders' Equity Attributable to Parent 2.59B USD +16%
Liabilities and Equity 3.72B USD +14.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 130M USD
Net Cash Provided by (Used in) Financing Activities 69.9M USD +752%
Net Cash Provided by (Used in) Investing Activities -55M USD -30.6%
Common Stock, Shares Authorized 220M shares 0%
Common Stock, Shares, Issued 99.4M shares +0.71%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 145M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 241M USD -6.99%
Deferred Tax Assets, Valuation Allowance 112M USD +26.2%
Deferred Tax Assets, Gross 726M USD +33.9%
Operating Lease, Liability 496M USD +70.8%
Depreciation 5.3M USD +29.3%
Payments to Acquire Property, Plant, and Equipment 11.2M USD +31.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 340M USD +28.5%
Lessee, Operating Lease, Liability, to be Paid 654M USD +70.6%
Property, Plant and Equipment, Gross 189M USD +23%
Operating Lease, Liability, Current 40.6M USD +26.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 58.2M USD +67.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 41.8M USD +26.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 159M USD +70.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 59.1M USD +73.8%
Deferred Tax Assets, Operating Loss Carryforwards 50.5M USD +38.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 180M USD +48.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four 60.6M USD +74.1%
Operating Lease, Payments 6.1M USD +38.6%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 900K USD 0%
Interest Expense 4.6M USD -17.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%